| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 7, 1472-1483, Copyright © 1993 by Endocrine Society
ARTICLES |
C Ambrosino, L Cicatiello, G Cobellis, R Addeo, V Sica, F Bresciani and A Weisz
Istituto di Patologia Generale e Oncologia, Prima Facolta di Medicina e Chirurgia, Universita di Napoli, Italy.
Estrogen hormones induce transient transcriptional activation of c-fos during the early phases of mitogenic stimulation of target cells. This is mediated by a functional estrogen response element (ERE) that in the human c-fos gene is localized 1kb up-stream of the transcription start site. This is the first known example of transient transcriptional activation induced by a steroid hormone acting via its nuclear receptor. Starting with the hypothesis that the product of c-fos (Fos) interferes with estrogen receptor (ER) activity on this gene promoter, generating in this way a feedback inhibition mechanism responsible for the rapid transcriptional down-regulation detected in vivo, we tested the effects of Fos overexpression on ER-mediated activation of the c- fos promoter in transfected HeLa cells. Transient transfection of an ER expression vector is followed by hormone-dependent trans-activation of reporter genes comprising the c-fos ERE linked to its own promoter. Coexpression of Fos in the cell induces a significant reduction in the activity of ER on the reporter genes. Fos antagonism is effective on both transcription activation functions of the receptor molecule and is independent of the nature of the target promoter. Furthermore, under the same experimental conditions, the estrogen-receptor complex antagonizes activation of an AP-1-responsive test gene by Fos. ER mutants deprived of the DNA-binding domain are efficient inhibitors of Fos activity, indicating that reciprocal antagonism is likely to be mediated by the formation of inactive complexes between the two factors. These results reveal the existence of a functional interference between the ER and Fos for regulation of c-fos protooncogene transcription. It is the first case in which the product of an estrogen-induced growth-related gene is shown to exert a negative feedback control on ER regulation of its own promoter.
This article has been cited by other articles:
![]() |
S. Fauconnet, I. Lascombe, E. Chabannes, G.-L. Adessi, B. Desvergne, W. Wahli, and H. Bittard Differential Regulation of Vascular Endothelial Growth Factor Expression by Peroxisome Proliferator-activated Receptors in Bladder Cancer Cells J. Biol. Chem., June 21, 2002; 277(26): 23534 - 23543. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gustavsson, K. Englund, M. Faxen, P. Sjoblom, B. Lindblom, and A. Blanck Tissue differences but limited sex steroid responsiveness of c-fos and c-jun in human fibroids and myometrium Mol. Hum. Reprod., January 1, 2000; 6(1): 55 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sahlin, H. Wang, B. Lindblom, H. Eriksson, A. Holmgren, and A. Blanck Thioredoxin expression in human myometrium and fibroids Mol. Hum. Reprod., January 1, 2000; 6(1): 60 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Chaidarun and J. M. Alexander A Tumor-Specific Truncated Estrogen Receptor Splice Variant Enhances Estrogen-Stimulated Gene Expression Mol. Endocrinol., September 1, 1998; 12(9): 1355 - 1366. [Abstract] [Full Text] |
||||
![]() |
E. Geimonen, E. Boylston, A. Royek, and J. Andersen Elevated Connexin-43 Expression in Term Human Myometrium Correlates with Elevated c-Jun Expression and Is Independent of Myometrial Estrogen Receptors J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1177 - 1185. [Abstract] [Full Text] |
||||
![]() |
M. von Lindern, L. Boer, O. Wessely, M. Parker, and H. Beug The Transactivation Domain AF-2 but Not the DNA-Binding Domain of the Estrogen Receptor Is Required to Inhibit Differentiation of Avian Erythroid Progenitors Mol. Endocrinol., February 1, 1998; 12(2): 263 - 277. [Abstract] [Full Text] |
||||
![]() |
D. L. Allen, N. A. Mitchner, T. E. Uveges, K. P. Nephew, S. Khan, and N. B. Jonathan Cell-Specific Induction of c-fos Expression in the Pituitary Gland by Estrogen Endocrinology, May 1, 1997; 138(5): 2128 - 2135. [Abstract] [Full Text] |
||||
![]() |
S. S. Chaidarun, A. Klibanski, and J. M. Alexander Tumor-Specific Expression of Alternatively Spliced Estrogen Receptor Messenger Ribonucleic Acid Variants in Human Pituitary Adenomas J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1058 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gianni, M. Terao, I. Fortino, M. LiCalzi, V. Viggiano, T. Barbui, A. Rambaldi, and E. Garattini Stat1 Is Induced and Activated by All-Trans Retinoic Acid in Acute Promyelocytic Leukemia Cells Blood, February 1, 1997; 89(3): 1001 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Geimonen, W. Jiang, M. Ali, G. I. Fishman, R. E. Garfield, and J. Andersen Activation of Protein Kinase C in Human Uterine Smooth Muscle Induces connexin-43 Gene Transcription through an AP-1 Site in the Promoter Sequence J. Biol. Chem., September 27, 1996; 271(39): 23667 - 23674. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |